RITUXIMAB-PVVR for Interstitial lung disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 73 adverse event reports in the FDA FAERS database where RITUXIMAB-PVVR was used for Interstitial lung disease.
Most Reported Side Effects for RITUXIMAB-PVVR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,079 | 49.4% | 209 | 502 |
| Intentional product use issue | 627 | 14.9% | 56 | 146 |
| Condition aggravated | 514 | 12.2% | 26 | 147 |
| Death | 338 | 8.0% | 338 | 63 |
| Covid-19 | 322 | 7.7% | 39 | 135 |
| Fatigue | 318 | 7.6% | 15 | 84 |
| Dyspnoea | 314 | 7.5% | 27 | 104 |
| Inappropriate schedule of product administration | 311 | 7.4% | 21 | 77 |
| Headache | 291 | 6.9% | 8 | 77 |
| Pruritus | 288 | 6.8% | 4 | 35 |
| Nausea | 286 | 6.8% | 8 | 76 |
| Malaise | 275 | 6.5% | 28 | 95 |
| Pain | 271 | 6.4% | 13 | 79 |
| Throat irritation | 259 | 6.2% | 1 | 30 |
| Cough | 249 | 5.9% | 15 | 64 |
Other Indications for RITUXIMAB-PVVR
Rheumatoid arthritis (1,659)
Granulomatosis with polyangiitis (745)
Microscopic polyangiitis (174)
Multiple sclerosis (106)
Systemic lupus erythematosus (105)
Glomerulonephritis membranous (65)
Anti-neutrophil cytoplasmic antibody positive vasculitis (62)
Sjogren's syndrome (54)
Product used for unknown indication (52)
Pemphigus (51)
Other Drugs Used for Interstitial lung disease
NINTEDANIB (2,999)
PIRFENIDONE (1,657)
RITUXIMAB (1,074)
PREDNISOLONE (879)
MYCOPHENOLATE MOFETIL (822)
METHYLPREDNISOLONE (744)
CYCLOPHOSPHAMIDE (623)
TACROLIMUS (565)
PREDNISONE (453)
CYCLOSPORINE (385)